Intern, Biostatistics

Intern, Biostatistics

Cambridge, MA

Requisition Number: 25-Intern10

 

How will your role help us transform hope into reality?

In this 10–12-week summer program, the selected individual will work closely with experienced statisticians and clinical researches on a research project that addresses research or business needs. Throughout the program, you will have the opportunity to learn about general study designs, data collection and statistical methods in clinical trial setting and apply your expertise to address project needs. At the end of the internship, you are expected to present final findings from the project to company-wide audience.

 

What will you do?

 

Projects will be crafted along one or multiple of the following key areas based on interest and business needs:

• Deep dive into clinical data from early to late-phase studies to gain further understanding of disease characteristics.
• Explore different endpoints that could better capture disease-related clinical outcomes.
• Perform other responsibilities as assigned.

 

What minimum qualifications do we require?

• Currently enrolled in a master or PhD program from an accredited college or university
• Pursuing a degree in Bio/statistics, Data Science, or related fields
• Interested in Clinical research, data mining and machine learning techniques

 

What additional qualifications will make you a stronger candidate?

• Commitment to our Core Values: Patients First, Thoughtfulness, Urgency, Trust, Optimism

 

ONSITE EXPECTATIONS – Hybrid, but 3-4 days on site is recommended

DRESS CODE - Business casual:

• Slacks or business dress pants, khakis, chinos, dresses, dark jeans without holes
• Button-down shirts, sweaters, blouses, henleys or polo shirts
• Optional cardigans, blazers or sports coats (especially for the colder months)
• Closed-toed shoes such as loafers, Oxfords, boots, pumps or flats
• Simple, professional accessories such as scarves, belts or jewelry

PROGRAM DATES - Tuesday, May 27th through Friday, August 15th

PAY RANGE PER HOUR:

High School Students

$20.00

Rising Sophomore

$23.00

Rising Junior/Senior

$25.00

Masters

$30.00

PhD

$35.00

 

 

Why Blueprint?

At Blueprint Medicines, we achieve impactful results because of our global crew of compassionate innovators – the Blue Crew. Through authentic relationships and our collective entrepreneurial spirit and action, we are each empowered to take ownership and execute with strategic prioritization. We put trust in our people to break through norms and conventions using their individual strengths and insights, which drives our success.

 

Equity, Diversity, Inclusion and Affirmative Action

At Blueprint Medicines, we foster a culture of equity, diversity and inclusion.  A proud Equal Employment Opportunity and Affirmative Action employer, we consider all qualified applicants without regard to race, color, sex, gender identity or expression, sexual orientation, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, or any other characteristic protected under applicable law.  We are also an E-Verify Employer.  We will make reasonable accommodations, absent undue hardship, for qualified individuals with known disabilities. If you are an individual with a disability in need of an accommodation with the application or recruiting process, please reach out to TotalRewards@blueprintmedicines.com. 

For more information, please see our EEO-AA Policy Statement, the E-Verify Participation Poster, the Right to Work Poster, and/or the EEO Know Your Rights Poster, as well as our Pay Transparency Statement. 

 

Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines, including bringing our medicine to patients with systemic mastocytosis (SM) in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases including SM and chronic urticaria, breast cancer and other solid tumors.